Clinical Trial

Impact of Clinician-administered Vaginal Live Biotherapeutic Product

Enrolling by Invitation Early Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated May 1, 2026 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is an open-label, single-arm, Phase Ib trial assessing the consistency of response and colonization kinetics of a vaginally inserted live biotherapeutic intervention with optimized adherence.
Protocol Amendment History 3 changes
critical Trial status changed: Not Yet Recruiting → Enrolling by Invitation 2026-05-02
notable Primary completion pushed: 2026-05-30 -> 2026-06-30 2026-05-02
minor Completion pushed: 2026-05-30 -> 2026-06-30 2026-05-02
Trial Details
NCT Number NCT07305844
Lead Sponsor Caroline Mitchell
Conditions Bacterial Vaginosis
Enrollment 71 participants
Start Date 2026-04-28
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-01